Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 978913, 9 pages
http://dx.doi.org/10.1100/2012/978913
Review Article

An Alternative Paradigm for the Role of Antimalarial Plants in Africa

David H. Murdock Research Institute, Kannapolis, NC 28081, USA

Received 26 October 2011; Accepted 15 December 2011

Academic Editor: Yasushi Shigeri

Copyright © 2012 Steven Maranz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kofi-Tsekpo, “Institutionalization of African traditional medicine in health care systems in Africa,” The African Journal of Health Sciences, vol. 11, no. 1-2, pp. i–ii, 2004. View at Google Scholar
  2. D. M. Maslove, A. Mnyusiwalla, E. J. Mills, J. McGowan, A. Attaran, and K. Wilson, “Barriers to the effective treatment and prevention of malaria in Africa: a systematic review of qualitative studies,” BMC International Health and Human Rights, vol. 9, no. 1, article 26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Essé, J. Utzinger, A. B. Tschannen et al., “Social and cultural aspects of 'malaria' and its control in central Côte d'Ivoire,” Malaria Journal, vol. 7, article 224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. WHO, World malaria Report, WHO Press, Geneva, Switzerland, 2010.
  5. ORTM, “Inch Allah documentary, 52 min,” Produced by Moussa Ouane. Bamako, Mali, 2004.
  6. Bill & Melinda Gates Foundation, Malaria Strategy Overview, 2009, http://www.gatesfoundation.org/global-health/Documents/malaria-strategy.pdf.
  7. P. D. Sene, D. Ndiaye, D. V. Tyne et al., “Monitoring ex vivo malaria drug susceptibility in Senegal after introduction of artemisinin-based combination therapies,” in Proceedings of the Annual Meeting of American Society of Tropical Medicine and Hygiene, Atlanta, Ga, USA, November 2010.
  8. A. M. Dondorp, F. Nosten, P. Yi et al., “Artemisinin resistance in Plasmodium falciparum malaria,” The New England Journal of Medicine, vol. 361, no. 5, pp. 455–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Tu, “The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine,” Nature Medicine, vol. 17, no. 10, pp. 1217–1220, 2011. View at Publisher · View at Google Scholar
  10. H. M. Burkhill, The Useful Plants of West Tropical Africa, Complete Set of Volumes 1–6, Royal Botanic Gardens, Kew, UK, 2004.
  11. H. J. Von Maydell, Arbres et Arbustes du Sahel: Leurs Caracteristiques et Leurs Utilisations, Margaf, Weikersheim, Germany, 1984.
  12. S. A. Khalid, A. Farouk, T. G. Geary, and J. B. Jensen, “Potential antimalarial candidates from African plants: an in vitro approach using Plasmodium falciparum,” Journal of Ethnopharmacology, vol. 15, no. 2, pp. 201–209, 1986. View at Google Scholar · View at Scopus
  13. M. S. A. Mohammed, “Traditional medicinal plants and Malaria in Africa,” in African Natural Plant Products: New Discoveries and Challenges in Chemistry and Quality, N. H. Juliani, Ed., ACS Symposium Series, chapter 12, American Chemical Society, Washington, DC, USA, 2010. View at Google Scholar
  14. G. M. Rukunga, J. W. Gathirwa, S. A. Omar et al., “Anti-plasmodial activity of the extracts of some Kenyan medicinal plants,” Journal of Ethnopharmacology, vol. 121, no. 2, pp. 282–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Pillay, V. J. Maharaj, and P. J. Smith, “Investigating South African plants as a source of new antimalarial drugs,” Journal of Ethnopharmacology, vol. 119, no. 3, pp. 438–454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. N. Soh and F. Benoit-Vical, “Are West African plants a source of future antimalarial drugs?” Journal of Ethnopharmacology, vol. 114, no. 2, pp. 130–140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. MacKinnon, T. Durst, J. T. Arnason et al., “Antimalarial activity of tropical Meliaceae extracts and gedunin derivatives,” Journal of Natural Products, vol. 60, no. 4, pp. 336–341, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. G. P. Talwar, S. Shah, S. Mukherjee, and R. Chabra, “Induced termination of pregnancy by purified extracts of Azadirachta Indica (Neem): mechanisms involved,” American Journal of Reproductive Immunology, vol. 37, no. 6, pp. 485–491, 1997. View at Google Scholar · View at Scopus
  19. S. J. Boeke, M. G. Boersma, G. M. Alink et al., “Safety evaluation of neem (Azadirachta indica) derived pesticides,” Journal of Ethnopharmacology, vol. 94, no. 1, pp. 25–41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. B. Conolly and W. K. Lutz, “Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment,” Toxicological Sciences, vol. 77, no. 1, pp. 151–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Jana and J. Paliwal, “Novel molecular targets for antimalarial chemotherapy,” International Journal of Antimicrobial Agents, vol. 30, no. 1, pp. 4–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Choi, P. Mukherjee, and M. A. Avery, “The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs,” Current Medicinal Chemistry, vol. 15, no. 2, pp. 161–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. F. J. Gamo, L. M. Sanz, J. Vidal et al., “Thousands of chemical starting points for antimalarial lead identification,” Nature, vol. 465, no. 7296, pp. 305–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Weisman, A. P. Liou, A. A. Shelat, F. E. Cohen, R. K. Guy, and J. L. DeRisi, “Searching for new antimalarial therapeutics amongst known drugs,” Chemical Biology and Drug Design, vol. 67, no. 6, pp. 409–416, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. L. B. Akella and D. DeCaprio, “Cheminformatics approaches to analyze diversity in compound screening libraries,” Current Opinion in Chemical Biology, vol. 14, no. 3, pp. 325–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Lucumi, C. Darling, H. Jo et al., “Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 9, pp. 3597–3604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Phillips and P. K. Rathod, “Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy,” Infectious Disorders—Drug Targets, vol. 10, no. 3, pp. 226–239, 2010. View at Google Scholar · View at Scopus
  28. D. J. Roberts and T. N. Williams, “Haemoglobinopathies and resistance to malaria,” Redox Report, vol. 8, no. 5, pp. 304–310, 2003. View at Publisher · View at Google Scholar
  29. C. A. Guerra, R. E. Howes, A. P. Patil et al., “The international limits and population at risk of Plasmodium vivax transmission in 2009,” PLoS Neglected Tropical Diseases, vol. 4, no. 8, article e774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Soranzo, B. Bufe, P. C. Sabeti et al., “Positive selection on a high-sensitivity allele of the human bitter-taste receptor TAS2R16 by the N172 allele may have driven the signal of selection at an early stage of human evolution,” Current Biology, vol. 15, no. 14, pp. 1257–1265, 2005. View at Publisher · View at Google Scholar
  31. M. C. Campbell and S. A. Tishkoff, “African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping,” Annual Review of Genomics and Human Genetics, vol. 9, pp. 403–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. L. Doolan, C. Dobaño, and J. K. Baird, “Acquired immunity to Malaria,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 13–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. F. Trape and C. Rogier, “Combating malaria morbidity and mortality by reducing transmission,” Parasitology Today, vol. 12, no. 6, pp. 236–240, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Maranz and K. W. Deitsch, “Plasmodicidal drugs vs. immunogenic compounds: the potential of dietary flavonoids to attenuate malaria infections and build host immunity,” in Proceedings of the Annual Meeting of American Society of Tropical Medicine and Hygiene, Atlanta, Ga, USA, November 2010.
  35. J. F. Trape, G. Pison, A. Spiegel, C. Enel, and C. Rogier, “Combating malaria in Africa,” Trends in Parasitology, vol. 18, no. 5, pp. 224–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. L. C. Jackson, “Two evolutionary models for the interactions of dietary organic cyanogens, hemoglobins, and falciparum malaria,” American Journal of Human Biology, vol. 2, pp. 521–532, 1991. View at Google Scholar
  37. P. N. Gillette, J. M. Manning, and A. Cerami, “Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 11, pp. 2791–2793, 1971. View at Google Scholar · View at Scopus
  38. L. C. Jackson, M. Oseguera, S. Medrano, and Y. L. Kim, “Carbamylation of hemoglobin in vivo with chronic sublethal dietary cyanide: implications for hemoglobin S,” Biochemical Medicine and Metabolic Biology, vol. 39, no. 1, pp. 64–68, 1988. View at Google Scholar · View at Scopus
  39. S. Wooding, “Evolution: a study in bad taste?” Current Biology, vol. 15, no. 19, pp. R805–R807, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. R. J. Hillocks, “Cassava in Africa,” in Cassava: Biology, Production and Utilization, R. J. Hillocks, J. M. Thresh, and A. Bellotti, Eds., p. 352, Cabi Publishing, New York, NY, USA, 2002. View at Google Scholar
  41. X. Pourrut and V. Robert, “Absence of plasmodial infection among wild monkeys in northern Senegal?” Bulletin de la Societe de Pathologie Exotique, vol. 102, no. 1, pp. 17–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Maranz, Z. Wiesman, and N. Garti, “Phenolic constituents of shea (Vitellaria paradoxa) kernels,” Journal of Agricultural and Food Chemistry, vol. 51, no. 21, pp. 6268–6273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Maranz and Z. Wiesman, “Influence of climate on the tocopherol content of Shea butter,” Journal of Agricultural and Food Chemistry, vol. 52, no. 10, pp. 2934–2937, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Maranz, “Climate stress and active compound maxima in the African Sahel,” in Proceedings of the Annual Meeting of the Society for Economic Botany, Chicago, Ill, USA, June 2007.
  45. F. Kaplan, J. Kopka, D. W. Haskell et al., “Exploring the temperature-stress metabolome of Arabidopsis,” Plant Physiology, vol. 136, no. 4, pp. 4159–4168, 2004. View at Google Scholar · View at Scopus
  46. W. J. Wang, X. Y. Li and , and Y. G. Zu, “Dynamic feature of flavonoids content in different organs of larch (Larix gmelinii),” Journal of Forestry Research, vol. 16, no. 2, pp. 89–92, 2005. View at Google Scholar
  47. Y. Go, Y. Satta, O. Takenaka, and N. Takahata, “Lineage-specific loss of function of bitter taste receptor genes in humans and nonhuman primates,” Genetics, vol. 170, no. 1, pp. 313–326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. P. K. Gillman, “Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors,” Journal of Clinical Psychopharmacology, vol. 31, no. 1, pp. 66–74, 2011. View at Publisher · View at Google Scholar
  49. D. J. McKenna, G. H. N. Towers, and F. Abbott, “Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of Ayahuasca,” Journal of Ethnopharmacology, vol. 10, no. 2, pp. 195–223, 1984. View at Google Scholar · View at Scopus
  50. A. Astulla, K. Zaima, Y. Matsuno et al., “Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities,” Journal of Natural Medicines, vol. 62, no. 4, pp. 470–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Farouk, A. Laroubi, R. Aboufatima, A. Benharref, and A. Chait, “Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: possible mechanisms involved,” Journal of Ethnopharmacology, vol. 115, no. 3, pp. 449–454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Fiot, S. Sanon, N. Azas et al., “Phytochemical and pharmacological study of roots and leaves of Guiera senegalensis J.F. Gmel (Combretaceae),” Journal of Ethnopharmacology, vol. 106, no. 2, pp. 173–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Chittrakarn, N. Keawpradub, K. Sawangjaroen, S. Kansenalak, and B. Janchawee, “The neuromuscular blockade produced by pure alkaloid, mitragynine and methanol extract of kratom leaves (Mitragyna speciosa Korth.),” Journal of Ethnopharmacology, vol. 129, no. 3, pp. 344–349, 2010. View at Publisher · View at Google Scholar
  54. F. P. Guengerich, “Cytochrome P450 and chemical toxicology,” Chemical Research in Toxicology, vol. 21, no. 1, pp. 70–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. S. L. Hsiu, Y. C. Hou, Y. H. Wang, C. W. Tsao, S. F. Su, and P. D. L. Chao, “Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats,” Life Sciences, vol. 72, no. 3, pp. 227–235, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. J. L. Raucy, “Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products,” Drug Metabolism and Disposition, vol. 31, no. 5, pp. 533–539, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. D. G. Bailey, G. K. Dresser, J. H. Kreeft, C. Munoz, D. J. Freeman, and J. R. Bend, “Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients,” Clinical Pharmacology and Therapeutics, vol. 68, no. 5, pp. 468–477, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. R. M. Fairhurst, D. I. Baruch, N. J. Brittain et al., “Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria,” Nature, vol. 435, no. 7045, pp. 1117–1121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Verra, G. Bancone, P. Avellino, I. Blot, J. Simporé, and D. Modiano, “Haemoglobin C and S in natural selection against Plasmodium falciparum malaria: a plethora or a single shared adaptive mechanism?” Parassitologia, vol. 49, no. 4, pp. 209–213, 2007. View at Google Scholar · View at Scopus
  60. Q. Chen, M. Schlichtherle, and M. Wahlgren, “Molecular aspects of severe malaria,” Clinical Microbiology Reviews, vol. 13, no. 3, pp. 439–450, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. J. F. Wang-Polagruto, A. C. Villablanca, J. A. Polagruto et al., “Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women,” Journal of Cardiovascular Pharmacology, vol. 47, supplement 2, pp. S177–S186, 2006. View at Publisher · View at Google Scholar
  62. N. D. L. Fisher, F. A. Sorond, and N. K. Hollenberg, “Cocoa flavanols and brain perfusion,” Journal of Cardiovascular Pharmacology, vol. 47, supplement 2, pp. S210–S214, 2006. View at Publisher · View at Google Scholar
  63. H. Schroeter, C. Heiss, J. Balzer et al., “(−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 4, pp. 1024–1029, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Dormeyer, Y. Adams, B. Kramer et al., “Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 2, pp. 724–730, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. I. R. Chandrashekaran, C. G. Adda, C. A. MacRaild, R. F. Anders, and R. S. Norton, “Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2,” Biochemistry, vol. 49, no. 28, pp. 5899–5908, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Renouf, P. Guy, C. Marmet et al., “Plasma appearance and correlation between coffee and green tea metabolites in human subjects,” British Journal of Nutrition, vol. 104, no. 11, pp. 1635–1640, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. J. F. Hammerstone, S. A. Lazarus, A. E. Mitchell, R. Rucker, and H. H. Schmitz, “Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry,” Journal of Agricultural and Food Chemistry, vol. 47, no. 2, pp. 490–496, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. J. E. Chung, M. Kurisawa, Y. J. Kim, H. Uyama, and S. Kobayashi, “Amplification of antioxidant activity of catechin by polycondensation with acetaldehyde,” Biomacromolecules, vol. 5, no. 1, pp. 113–118, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Adams, S. L. Smith, R. Schwartz-Albiez, and K. T. Andrews, “Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36,” Parasitology Research, vol. 97, no. 4, pp. 290–294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. J. G. Beeson, W. Chai, S. J. Rogerson, A. M. Lawson, and G. V. Brown, “Inhibition of binding of malaria-infected erythrocytes by a tetradecasaccharide fraction from chondroitin sulfate A,” Infection and Immunity, vol. 66, no. 7, pp. 3397–3402, 1998. View at Google Scholar · View at Scopus